Does doxepin 5 mg cause weight gain?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 27, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Does Doxepin 5mg Cause Weight Gain?

At the low 5mg dose used for insomnia, doxepin appears to be weight-neutral and does not cause clinically significant weight gain. This is a critical distinction from higher antidepressant doses of doxepin (25-300mg), which are associated with weight gain.

Dose-Dependent Weight Effects

The weight gain risk with doxepin is highly dose-dependent:

  • Low-dose doxepin (3-6mg) for insomnia: Multiple clinical trials examining doxepin 3mg and 6mg for sleep maintenance insomnia found no significant weight gain as an adverse effect 1. The FDA-approved hypnotic dosing studies specifically monitored for side effects and reported headache, diarrhea, somnolence, and upper respiratory infections—but not weight gain 1.

  • Higher-dose doxepin (25-300mg) for depression: At antidepressant doses, doxepin is classified among tricyclic antidepressants that cause weight gain 2, 3. Guidelines consistently list doxepin alongside amitriptyline as tricyclics with the highest weight gain potential when used at therapeutic antidepressant doses 2. One study found significant weight gain with doxepin at antidepressant doses, comparable to amitriptyline 4.

Clinical Context

Your 5mg dose falls within the low-dose hypnotic range (3-6mg), not the antidepressant range. The 2017 American Academy of Sleep Medicine guidelines specifically recommend doxepin 3-6mg for sleep maintenance insomnia, with extensive safety data showing minimal adverse effects at these doses 1. The FDA label for low-dose doxepin lists weight gain as a potential side effect only in the context of higher antidepressant dosing 5.

Important Caveats

  • Individual variation exists: While population-level data shows no significant weight gain at 5mg, individual responses can vary
  • Duration matters: The insomnia trials were conducted over 4-12 weeks 1; longer-term weight effects at this dose are less well-studied
  • Monitor regardless: If you notice weight changes, discuss with your prescriber, as switching to alternative sleep medications (ramelteon, suvorexant) that are definitively weight-neutral may be appropriate

Alternative Considerations

If weight concerns are paramount, other insomnia medications are explicitly weight-neutral 2:

  • Benzodiazepine receptor agonists (zolpidem, eszopiclone)
  • Ramelteon (melatonin receptor agonist)
  • Non-benzodiazepine hypnotics

The bottom line: At 5mg for insomnia, doxepin should not cause weight gain based on clinical trial evidence, unlike the higher antidepressant doses where weight gain is a recognized side effect.

References

Guideline

clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an american academy of sleep medicine clinical practice guideline.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2017

Guideline

impact of concomitant medications on obstructive sleep apnoea.

British Journal of Pharmacology, 2017

Guideline

practical use of pharmacotherapy for obesity.

Gastroenterology, 2017

Research

[Weight gain during antidepressant therapy].

Psychiatria polska, 1992

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.